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897 Optimizing revascularization strategies in patients with multivessel coronary
disease: Impact of intracoronary pressure measurements
Michael Lindstaedt, MD, Markus K. Fritz, MD, Aydan Yazar, MD, Christian Perrey, MS,
Alfried Germing, MD, Peter H. Grewe, MD, Axel M. Laczkovics, MD, Andreas Mu¨gge, MD,
and Waldemar Bojara, MD, Bochum, Germany
In 25 patients with multivessel disease, intermediate coronary lesions, and inconclusive stress-
test results, intracoronary pressure measurements were performed. Revascularization strategies
based on angiographic information alone were compared with treatment strategies based on
measurement of the myocardial fractional flow reserve. The original treatment recommendation
was changed in 36% of cases on the basis of the functional measurement results.
Cardiothoracic
Transplantation
(TX)
904 Quantitative analysis of survival of transplanted smooth muscle cells with
real-time polymerase chain reaction
Tamotsu Yasuda, MD, PhD, Richard D. Weisel, MD, Chris Kiani, PhD,
Donald A. G. Mickle, MD, Manjula Maganti, MSc, and Ren-Ke Li, MD, PhD,
Toronto, Ontario, Canada
Male smooth muscle cells were transplanted into normal and infarcted female myocardium, and
the survival of the implanted cells was evaluated with real-time PCR targeting the Y
chromosome. The accuracy of the technique was excellent, and cell survival after
transplantation decreased progressively during the subsequent 4 weeks.
912 High central venous pressure is associated with prolonged mechanical
ventilation and increased mortality after lung transplantation
D. V. Pilcher, MBBS, MRCP, C. D. Scheinkestel, MBBS, FRACP, FJFICM, G. I. Snell, MBBS,
FRACP, A. Davey-Quinn, MBBS, FRCA, M. J. Bailey, BSc(Hons), MSc (Statistics), and
T. J. Williams, MBBS, FRACP, Prahran, Australia
Low CVP and PCWP are routinely advocated to reduce pulmonary edema after lung
transplantation. However, this strategy is not evidence based. In this retrospective review of
118 patients, a high CVP was associated with adverse early outcome after lung transplantation.
919 Lung transplantation with lungs from donors fifty years of age and older
Stefan Fischer, MD, MSc, Bernhard Gohrbandt, MD, Pascal Struckmeier, MS,
Jost Niedermeyer, MD, Andre Simon, MD, Christian Hagl, MD, Klaus Kallenbach, MD,
Axel Haverich, MD, and Martin Strüber, MD, Hannover, Germany
With the increasing need for donor organs, singular programs have started to accept lungs from
so-called marginal donors for transplantation. Elderly donors have repeatedly been considered
as marginal donors. This, however, has not been systematically analyzed. In this study we
reviewed our experience in lung transplantation with lungs from donors aged 50 years or older.
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